AAV Vector Consortia Address Quality Assays, Endpoints

Two outside groups aim to help CBER on gene therapy questions from ‘N of one’ to markers for hemophilia.

gene therapy collaboration
• Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies